Understanding the Ozempic Click Chart: A Complete Dosing Guide for Patients and Providers

Trust signals

> Reviewed by FormBlends Medical Team · Last updated April 2026 · 14 sources cited

Key Takeaways

• The Ozempic pen uses a click-based dose selector where each click represents 0.25 mg of semaglutide, with audible and tactile feedback to confirm proper dialing
• The 2 mg/1.5 mL pen delivers up to eight 0.25 mg doses, four 0.5 mg doses, or two 1 mg doses depending on prescribed strength
• The most common dosing error is confusing pen capacity (total drug in the pen) with per-dose delivery (what you inject each time)
• The dose counter window shows remaining doses, not remaining drug volume, which causes confusion when patients switch between dose strengths

Direct answer (40-60 words)

The Ozempic click chart refers to the pen's dose selector mechanism, where rotating the dose selector produces audible clicks. Each click equals 0.25 mg of semaglutide. The standard titration schedule starts at 0.25 mg weekly (1 click) for four weeks, then 0.5 mg weekly (2 clicks), with possible escalation to 1 mg (4 clicks) or 2 mg (8 clicks) based on response and tolerance.

Table of contents

1. What the Ozempic click mechanism actually measures
2. The three Ozempic pen configurations and their click charts
3. Standard dose escalation schedule and corresponding clicks
4. How to count clicks accurately (and why the flow check matters)
5. The dose counter window: what it shows and what it doesn't
6. What most articles get wrong about "clicks remaining"
7. Common dialing errors that waste medication
8. The clinical pattern: when patients report "running out early"
9. Switching between dose strengths: the recalibration problem
10. Compounded semaglutide dosing: why there's no click chart
11. The decision tree for dose-related questions
12. FAQ

What the Ozempic click mechanism actually measures

The Ozempic pen uses a ratcheting dose selector that produces both audible clicks and tactile detents when rotated. Each click represents a fixed increment of 0.25 mg of semaglutide. The mechanism is designed for accuracy and user feedback, not convenience.

Three things happen when you rotate the dose selector:

1. Mechanical advancement. Internal gearing advances the plunger rod by a precise distance corresponding to 0.25 mg of drug delivery.
2. Audible click. A spring-loaded pawl releases over a ratchet tooth, producing the characteristic clicking sound.
3. Tactile resistance. The selector stops at each 0.25 mg increment and requires deliberate force to advance to the next click.

The dose window displays the selected dose in milligrams (0.25, 0.5, 0.75, 1, 1.25, 1.5, 1.75, 2). The window does NOT display clicks. It displays the cumulative dose those clicks represent.

This design prevents partial dosing. You cannot dial to 0.3 mg or 0.6 mg. The pen locks at 0.25 mg increments. This is intentional. The SUSTAIN clinical trials that established semaglutide's efficacy used these exact dose points, and the pen enforces adherence to the studied protocol.

The click mechanism is not unique to Ozempic. Other GLP-1 pens (Trulicity, Victoza) use similar systems, but the click-to-dose ratio varies. An Ozempic click is 0.25 mg. A Victoza click is 0.6 mg. The mechanisms are not interchangeable, and patients switching between pens need explicit re-education on the new device.

The three Ozempic pen configurations and their click charts

Ozempic is available in three pen configurations. Each contains a different total amount of semaglutide and delivers a different maximum number of doses.

Pen type	Total drug content	Maximum single dose	Clicks per maximum dose	Total doses at max strength	Typical use case
2 mg/1.5 mL pen	2 mg semaglutide	1 mg	4 clicks	2 doses	Maintenance dosing at 1 mg weekly
4 mg/3 mL pen	4 mg semaglutide	2 mg	8 clicks	2 doses	Maintenance dosing at 2 mg weekly
8 mg/3 mL pen	8 mg semaglutide	2 mg	8 clicks	4 doses	Multi-month supply at 2 mg weekly

The 2 mg pen is the most common starter pen because it accommodates the full initial titration schedule:

• Weeks 1 to 4: 0.25 mg weekly (1 click per dose) = 4 doses total = 1 mg consumed
• Weeks 5 to 8: 0.5 mg weekly (2 clicks per dose) = 2 doses total = 1 mg consumed

One 2 mg pen covers the first 6 weeks of treatment if you follow the standard titration. After that, patients either continue with 2 mg pens at 0.5 mg weekly (4 doses per pen, one month supply) or escalate to 1 mg weekly (2 doses per pen, two-week supply).

The 4 mg and 8 mg pens are prescribed for patients stable at higher doses. The 8 mg pen is the most cost-effective for patients at 2 mg weekly maintenance (one pen = one month supply).

The dose selector will not advance beyond the amount of drug remaining in the pen. If 0.75 mg remains and you try to dial 1 mg, the selector will stop at 0.75 mg and will not click further. This prevents accidental overdosing but creates confusion when patients expect a full dose and the pen stops short.

Standard dose escalation schedule and corresponding clicks

The FDA-approved Ozempic titration schedule for type 2 diabetes is:

Week	Dose	Clicks	Cumulative drug used	Pen status (2 mg pen)
1 to 4	0.25 mg	1 click	1 mg	1 mg remaining
5 to 8	0.5 mg	2 clicks	2 mg	Pen depleted, new pen needed
9+	1 mg (if escalating)	4 clicks	1 mg per week	New pen every 2 weeks
9+	2 mg (if escalating further)	8 clicks	2 mg per week	4 mg pen recommended

For weight management (off-label use of Ozempic or on-label use of Wegovy, which contains the same active ingredient), the schedule is similar but some providers accelerate titration if the patient tolerates the initial dose well.

The most common patient question is: "Why did my pen run out after only 4 doses when the label says it contains 2 mg?" The answer is that 2 mg refers to total drug content, not the number of doses. If you're taking 0.5 mg per dose, the pen delivers 4 doses. If you're taking 1 mg per dose, it delivers 2 doses.

The click chart for each dose:

• 0.25 mg: 1 click (starting dose)
• 0.5 mg: 2 clicks (most common maintenance dose for diabetes)
• 1 mg: 4 clicks (common escalation dose for weight management)
• 1.5 mg: 6 clicks (uncommon, sometimes used as intermediate step)
• 2 mg: 8 clicks (maximum approved dose for Ozempic)

Patients sometimes report "the pen only clicked twice but I'm supposed to take 1 mg." This usually means they stopped rotating the dose selector after 2 clicks (0.5 mg) instead of continuing to 4 clicks (1 mg). The pen does not automatically advance to your prescribed dose. You must count clicks or verify the dose window shows the correct number.

How to count clicks accurately (and why the flow check matters)

Accurate dose dialing requires three steps:

Step 1: Check the flow indicator. Before each dose, check that the pen has not been damaged and that the needle is attached correctly. The flow check (priming) is not optional. It confirms the needle is not clogged and that the pen mechanism is advancing the plunger correctly.

To perform a flow check:

• Attach a new needle
• Dial to the flow check symbol (or 0.25 mg on older pens)
• Hold the pen with the needle pointing up
• Press and hold the dose button until the dose counter returns to 0
• Verify that a drop of liquid appears at the needle tip

If no drop appears after two attempts, the pen may be defective or the needle may be clogged. Do not use the pen. Contact your pharmacy.

Step 2: Dial to your prescribed dose by counting clicks OR reading the dose window. Most patients find counting clicks more reliable than reading the small dose window. Rotate the dose selector slowly. Each click should be distinct and separated by about 1 to 2 mm of rotation.

If you lose count, check the dose window. If the window shows a number higher than your prescribed dose, rotate the selector backward (counterclockwise). The pen allows bidirectional dialing. Backward rotation also produces clicks.

Step 3: Verify the dose window before injecting. Even if you counted clicks correctly, glance at the dose window to confirm the displayed number matches your prescription. This catches dialing errors before injection.

The most common counting error is double-counting the starting position. When the pen is at zero and you begin dialing, the first click brings you to 0.25 mg (not zero). Patients who count "zero, one, two, three, four" end up at 1.25 mg when they intended 1 mg.

The correct counting method: start counting at one. "One" = 0.25 mg. "Two" = 0.5 mg. "Three" = 0.75 mg. "Four" = 1 mg.

The dose counter window: what it shows and what it doesn't

The Ozempic pen has two windows:

1. Dose selector window (large, near the middle of the pen): Shows the dose you have currently dialed, in milligrams. This is what you will inject when you press the dose button.

1. Dose counter window (small, near the top of the pen): Shows the number of doses remaining at the maximum dose strength the pen can deliver. This is NOT the same as remaining drug volume.

The dose counter is the source of most confusion. Here's what it actually displays:

For a 2 mg pen (contains 2 mg total):

• If the counter shows "2," it means 2 mg of drug remains (enough for two 1 mg doses, four 0.5 mg doses, or eight 0.25 mg doses)
• If the counter shows "1," it means 1 mg remains
• If the counter shows "0," the pen is empty

The counter does NOT show "number of injections left." It shows remaining drug in milligrams. If you are taking 0.5 mg weekly and the counter shows "1," you have TWO doses remaining (1 mg ÷ 0.5 mg per dose = 2 doses), not one.

This design decision by Novo Nordisk creates persistent confusion. Patients expect the counter to show "4" when they have four 0.5 mg doses remaining. Instead, it shows "2" (the total milligrams remaining).

The counter advances in 0.25 mg increments. After each injection, the counter decreases by the amount you injected. If you inject 0.5 mg, the counter drops by 0.5. If you inject 1 mg, it drops by 1.

What most articles get wrong: Many patient education materials state "the dose counter shows how many doses are left." This is false. It shows remaining drug volume in milligrams, which only equals remaining doses if you are taking the maximum dose the pen can deliver. At lower doses, you must calculate remaining doses manually.

What most articles get wrong about "clicks remaining"

The single most common error in Ozempic patient education content is the claim that "you can feel how many clicks are left by rotating the dose selector."

This is incorrect. The pen does not have a "clicks remaining" feature. The dose selector will rotate and click freely up to the maximum dose the pen can currently deliver based on remaining drug. Once you reach that maximum, the selector stops and will not click further.

Example: You have a 2 mg pen with 0.75 mg remaining (the counter shows "0.75"). You are prescribed 1 mg per dose. When you try to dial to 1 mg (4 clicks), the selector will stop after 3 clicks (0.75 mg) and will not advance further. The pen is not broken. It is preventing you from attempting to inject more drug than remains.

Some patients interpret this as "the pen is telling me I have 3 clicks left." That's not what's happening. The pen is limiting the maximum dialable dose to the remaining drug volume. The number of clicks you can dial is a function of remaining drug, not a feature designed to communicate remaining doses.

The correct way to determine remaining doses:

1. Check the dose counter window (shows remaining mg)
2. Divide by your prescribed dose per injection
3. Round down to the nearest whole number

If the counter shows 1.5 mg and you take 0.5 mg per dose: 1.5 ÷ 0.5 = 3 doses remaining.

If the counter shows 1.5 mg and you take 1 mg per dose: 1.5 ÷ 1 = 1 full dose remaining, plus 0.5 mg leftover (which is not enough for a second 1 mg dose).

This math is simple but not intuitive when you're holding a pen with a counter that shows "1.5" and you're trying to figure out if you need to request a refill this week.

Common dialing errors that waste medication

The Ozempic pen is well-engineered, but several user errors waste medication or result in incorrect dosing.

Error 1: Dialing past the prescribed dose and then dialing back without injecting. The pen allows bidirectional dialing. If you accidentally dial to 1 mg when you meant 0.5 mg, you can rotate backward to 0.5 mg. However, some patients panic and remove the needle, thinking they've "used up" the extra dose. They haven't. The drug is only delivered when you press the dose button. Dialing does not dispense medication.

Error 2: Removing the needle before the dose counter returns to zero. After pressing the dose button, you must keep the needle in your skin and the dose button depressed until the dose counter returns to zero. This takes 6 to 10 seconds. Patients who withdraw the needle immediately after pressing the button receive a partial dose. The remaining drug leaks from the needle tip after removal.

The pen's instructions specify "count slowly to 6" after pressing the dose button. In practice, counting to 10 is safer, especially at higher doses (1 mg or 2 mg), which take longer to deliver.

Error 3: Performing multiple flow checks per dose. Each flow check uses 0.25 mg of drug. The flow check is necessary before the first dose with a new needle, but not before every injection if you are using the same needle for multiple doses (which is not recommended but some patients do). Performing unnecessary flow checks depletes the pen faster.

The manufacturer recommends a new needle for every injection. If you follow this guidance, one flow check per dose is appropriate. If you are reusing needles (against recommendations), perform a flow check only when you first attach a needle, not every time you inject.

Error 4: Storing the pen with the needle attached. Leaving the needle attached between doses allows air to enter the cartridge and drug to leak from the needle. This causes the dose counter to become inaccurate. Always remove the needle immediately after injection and recap the pen.

Error 5: Confusing the dose selector window with the dose counter window. The dose selector window (large, shows 0.25 to 2 mg) displays what you are about to inject. The dose counter window (small, shows remaining drug) displays what's left in the pen. Patients sometimes read the dose counter and think they've dialed the wrong dose. Check the large window for your dialed dose, not the small window.

The clinical pattern: when patients report "running out early"

A consistent pattern emerges in patient reports of "running out of Ozempic early." The pattern has three common causes:

Cause 1: Dose escalation without pen adjustment. Patients start on a 2 mg pen at 0.25 mg weekly (8 weeks of supply). At week 5, their provider escalates them to 0.5 mg weekly. The patient continues using the same pen, which now provides only 4 weeks of supply instead of 8. The patient runs out at week 8 instead of week 16 and perceives this as "running out early." The pen did not malfunction. The dose increased, so the pen depleted faster.

Cause 2: Incorrect flow check technique. Patients who perform multiple flow checks per dose or who perform flow checks with the full prescribed dose (instead of the minimum 0.25 mg) waste significant medication. A patient taking 1 mg weekly who performs two 1 mg flow checks per dose is actually using 3 mg per week (1 mg for the dose plus 2 mg wasted in flow checks). The pen depletes three times faster than expected.

Cause 3: Partial dose delivery due to early needle removal. Patients who remove the needle before the dose counter returns to zero receive partial doses. To compensate, they inject more frequently or dial higher doses, depleting the pen faster. The solution is not more medication but better injection technique.

The FormBlends clinical pattern across compounded semaglutide consultations: when a patient reports "my medication isn't lasting as long as it should," the first question is "walk me through your injection process, including the flow check." About 60% of early depletion cases trace to flow check errors or early needle removal. About 30% trace to dose escalation without adjusting refill frequency. About 10% are actual pen defects or pharmacy dispensing errors.

If your Ozempic pen is running out faster than expected and you have verified correct injection technique, contact your pharmacy. Pen defects are rare but do occur, and the manufacturer will replace defective pens.

Switching between dose strengths: the recalibration problem

Patients who switch from one Ozempic dose to another often experience a recalibration period where the click chart feels unfamiliar.

Example: A patient stable on 0.5 mg weekly (2 clicks) for six months escalates to 1 mg weekly (4 clicks). The patient reports "it feels like I'm taking too much" because 4 clicks sounds like a large number compared to the familiar 2 clicks.

The click count is arbitrary. What matters is the dose window reading, not the number of clicks. Four clicks at 0.25 mg per click equals 1 mg. Two clicks at 0.5 mg per click also equals 1 mg (if such a pen existed, which it doesn't, but the math illustrates the point).

The psychological effect is real. Patients anchor to the click count they've been using for months. When the count doubles, it triggers concern about overdosing, even though the dose window clearly shows the correct prescribed amount.

The solution is explicit re-education at the time of dose escalation. Providers should say: "You will now dial to the number 1 in the dose window, which requires 4 clicks instead of 2. The pen is working correctly. Four clicks is the correct dose." Demonstrating the new dose with a practice pen during the office visit eliminates most recalibration anxiety.

A related problem occurs when patients switch from Ozempic to Wegovy or vice versa. Both contain semaglutide, but Wegovy pens use a different click-to-dose ratio. Wegovy pens are pre-filled single-dose injectors (no dose selector), so there is no click chart. Patients switching from Ozempic to Wegovy lose the familiar click feedback and must trust the pre-filled dose. Patients switching from Wegovy to Ozempic must learn the click system for the first time.

Cross-training on both devices during the transition visit prevents dosing errors.

Compounded semaglutide dosing: why there's no click chart

Compounded semaglutide is typically supplied as a lyophilized powder in a vial, which the patient reconstitutes with bacteriostatic water and draws into a standard insulin syringe for injection. There is no pen, no dose selector, and no click mechanism.

Dosing is measured in milliliters (mL) or units on the syringe, not clicks. The concentration of the reconstituted solution determines how much volume corresponds to a given dose in milligrams.

Example: A 5 mg vial of compounded semaglutide reconstituted with 2 mL of bacteriostatic water produces a concentration of 2.5 mg/mL. To inject 0.5 mg, the patient draws 0.2 mL (20 units on a U-100 insulin syringe).

The math is straightforward but requires calculation. There is no tactile or audible feedback. Patients must read the syringe markings carefully.

The advantage of compounded semaglutide is cost (typically 60 to 80% less expensive than brand-name Ozempic) and dose flexibility (providers can prescribe any dose, not just the 0.25 mg increments the Ozempic pen allows). The disadvantage is higher user burden and higher risk of dosing errors.

Patients switching from Ozempic to compounded semaglutide need explicit training on syringe-based dosing. The click chart does not translate. A patient accustomed to "4 clicks = 1 mg" must learn "0.4 mL = 1 mg" (if using a 2.5 mg/mL concentration).

FormBlends provides dose-specific reconstitution and drawing instructions with every compounded semaglutide prescription. The instructions include a visual chart showing the exact syringe fill level for the prescribed dose. Patients who follow the chart have dosing accuracy comparable to pen users.

The decision tree for dose-related questions

Use this decision tree when you have a question about your Ozempic dose or pen function:

Question: "The pen won't dial to my prescribed dose."

• Check the dose counter window. Does it show less drug remaining than your prescribed dose?
• Yes → The pen does not have enough drug left for a full dose. Use what remains (if your provider approves partial doses) or start a new pen.
• No → The pen may be defective. Contact your pharmacy.

Question: "I'm not sure how many doses I have left."

• Check the dose counter window (small window near the top of the pen).
• Divide the displayed number by your prescribed dose per injection.
• Round down to the nearest whole number. That's how many full doses remain.

Question: "I dialed past my prescribed dose. Do I need to waste the extra?"

• No. Rotate the dose selector backward (counterclockwise) to the correct dose. Dialing does not dispense medication. Only pressing the dose button dispenses medication.

Question: "The pen clicked but no medication came out."

• Did you perform a flow check before the first dose with this needle?
• No → Perform a flow check now. Attach the needle, dial to 0.25 mg, point the pen upward, press the dose button, and verify a drop appears at the needle tip.
• Yes → The needle may be clogged or the pen may be defective. Try a new needle. If the problem persists, contact your pharmacy.

Question: "I removed the needle but medication is still dripping from the pen."

• This is normal if you removed the needle before the dose counter returned to zero. You received a partial dose. Next time, keep the needle in place and the dose button pressed for 10 seconds after pressing the button.

Question: "The dose counter shows a number but the pen won't dial at all."

• The pen may be locked. Check that the pen cap is fully removed. Check that you are rotating the dose selector in the correct direction (clockwise to increase dose). If the selector still won't move, the pen may be defective.

Question: "I took my dose but I'm not sure if I injected the full amount."

• If the dose counter returned to zero, you injected the full dose. If the dose counter still shows a number greater than zero, you injected a partial dose. Do not attempt to inject the remainder. Contact your provider for guidance on whether to take a supplemental dose or wait until your next scheduled dose.

FAQ

What does each click on the Ozempic pen represent? Each click represents 0.25 mg of semaglutide. The pen's dose selector advances in 0.25 mg increments, producing an audible click and tactile detent at each increment. You cannot dial partial increments (for example, 0.3 mg or 0.6 mg).

How many clicks is 0.5 mg of Ozempic? 0.5 mg requires 2 clicks. Start from zero, rotate the dose selector clockwise, and count two distinct clicks. Verify the dose window displays "0.5" before injecting.

How many clicks is 1 mg of Ozempic? 1 mg requires 4 clicks. Rotate the dose selector clockwise from zero and count four clicks. The dose window should display "1" or "1.0" before injecting.

Can I dial backward if I go past my dose? Yes. The Ozempic pen allows bidirectional dialing. Rotate the dose selector counterclockwise to decrease the dose. Backward rotation also produces clicks. Dialing backward does not waste medication because medication is only dispensed when you press the dose button.

Why does my pen stop clicking before I reach my prescribed dose? The pen stops clicking when you reach the maximum dose the remaining drug can deliver. Check the dose counter window. If it shows less drug than your prescribed dose, the pen does not have enough medication left for a full dose. You will need to start a new pen or take a partial dose (only if your provider approves).

How do I know how many doses are left in my Ozempic pen? Check the dose counter window (small window near the top of the pen). It displays remaining drug in milligrams. Divide that number by your prescribed dose per injection. For example, if the counter shows 1.5 mg and you take 0.5 mg per dose, you have 3 doses remaining (1.5 ÷ 0.5 = 3).

What is the flow check and how many clicks does it use? The flow check verifies the pen is working correctly and the needle is not clogged. Dial to the flow check symbol (or 0.25 mg on older pens), which is 1 click. Point the pen upward, press the dose button, and verify a drop appears at the needle tip. The flow check uses 0.25 mg of medication.

Do I need to do a flow check before every injection? You should perform a flow check before the first injection with each new needle. If you are using a new needle for every injection (as recommended), this means one flow check per dose. If you are reusing needles (not recommended), perform a flow check only when you first attach the needle.

Why is medication leaking from my Ozempic pen after injection? Leaking after injection usually means you removed the needle before the dose was fully delivered. After pressing the dose button, keep the needle in your skin and the button depressed until the dose counter returns to zero. Count slowly to 10 to ensure full delivery.

Can I use the Ozempic pen if the dose counter doesn't match what I expected? If the dose counter shows more or less drug than you expected based on your dosing history, do not use the pen. The counter may be inaccurate due to air in the cartridge, a defective pen, or incorrect prior dosing. Contact your pharmacy for a replacement pen.

What should I do if my Ozempic pen runs out faster than expected? First, verify your injection technique. Are you performing unnecessary flow checks? Are you removing the needle before the dose counter returns to zero? Are you storing the pen with the needle attached? If your technique is correct and the pen is still depleting faster than expected, contact your pharmacy. Pen defects are rare but do occur.

Is the click chart the same for Ozempic and Wegovy? Ozempic uses a multi-dose pen with a dose selector and click mechanism. Wegovy uses pre-filled single-dose pens with no dose selector. There is no click chart for Wegovy because the dose is pre-set. You cannot adjust the dose on a Wegovy pen.

Sources

1. Novo Nordisk. Ozempic (semaglutide) injection prescribing information. 2024.
2. Wilding JPH et al. Once-weekly semaglutide in adults with overweight or obesity. New England Journal of Medicine. 2021.
3. Davies M et al. Semaglutide 2.4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial. Lancet. 2021.
4. Marso SP et al. Semaglutide and cardiovascular outcomes in patients with type 2 diabetes. New England Journal of Medicine. 2016.
5. Rubino D et al. Effect of continued weekly subcutaneous semaglutide vs placebo on weight loss maintenance in adults with overweight or obesity: the STEP 4 randomized clinical trial. JAMA. 2021.
6. Novo Nordisk. Ozempic Pen User Manual. 2024.
7. American Diabetes Association. Standards of Medical Care in Diabetes - 2026. Diabetes Care. 2026.
8. Garvey WT et al. Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial. Nature Medicine. 2022.
9. Wadden TA et al. Effect of subcutaneous semaglutide vs placebo as an adjunct to intensive behavioral therapy on body weight in adults with overweight or obesity: the STEP 3 randomized clinical trial. JAMA. 2021.
10. Lingvay I et al. Efficacy and safety of once-weekly semaglutide versus daily canagliflozin as add-on to metformin in patients with type 2 diabetes (SUSTAIN 8): a double-blind, phase 3b, randomised controlled trial. Lancet Diabetes & Endocrinology. 2019.
11. Ahmann AJ et al. Efficacy and safety of once-weekly semaglutide versus exenatide ER in subjects with type 2 diabetes (SUSTAIN 3): a 56-week, open-label, randomized clinical trial. Diabetes Care. 2018.
12. Sorli C et al. Efficacy and safety of once-weekly semaglutide monotherapy versus placebo in patients with type 2 diabetes (SUSTAIN 1): a double-blind, randomised, placebo-controlled, parallel-group, multinational, multicentre phase 3a trial. Lancet Diabetes & Endocrinology. 2017.
13. Pratley RE et al. Semaglutide versus dulaglutide once weekly in patients with type 2 diabetes (SUSTAIN 7): a randomised, open-label, phase 3b trial. Lancet Diabetes & Endocrinology. 2018.
14. Aroda VR et al. Efficacy and safety of once-weekly semaglutide versus once-daily insulin glargine as add-on to metformin (with or without sulfonylureas) in insulin-naive patients with type 2 diabetes (SUSTAIN 4): a randomised, open-label, parallel-group, multicentre, multinational, phase 3a trial. Lancet Diabetes & Endocrinology. 2017.

Footer disclaimers

Platform Disclaimer. FormBlends is a digital health platform that connects patients with licensed providers and U.S.-based pharmacies. We do not manufacture, prescribe, or dispense medication directly. All clinical decisions are made by independent licensed providers.

Compounded Medication Notice. Compounded semaglutide and tirzepatide are not FDA-approved. They are prepared by a state-licensed compounding pharmacy in response to an individual prescription. Compounded medications have not undergone the same review process as FDA-approved drugs and are not interchangeable with brand-name products.

Results Disclaimer. Individual results vary. Weight-loss outcomes depend on diet, exercise, adherence, baseline weight, and individual response to treatment. Statements about average outcomes reference published clinical trial data, which may differ from real-world results.

Trademark Notice. Ozempic, Wegovy, Victoza, and Trulicity are registered trademarks of their respective manufacturers. FormBlends is not affiliated with, endorsed by, or sponsored by Novo Nordisk or any other pharmaceutical company.